Puerarin accelerates neural regeneration after sciatic nerve injury

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Puerarin, a natural isoflavone from Pueraria species, is known for protecting against cerebral ischemia.
• Peripheral nerve injuries can lead to significant functional deficits and challenges in regeneration.

Purpose of the Study:

• To investigate the potential of puerarin in promoting the repair of peripheral nerve injuries.
• To determine if puerarin influences key molecular markers and structural outcomes in sciatic nerve injury models.

Main Methods:

• Mouse models of sciatic nerve injury were established.
• Mice received daily intraperitoneal injections of puerarin at doses of 10, 5, or 2.5 mg/kg.
• Expression of growth-associated protein 43 (GAP-43) was analyzed in spinal cord segments.
• Muscle atrophy and nerve fiber regeneration were assessed at different time points post-injury.

Main Results:

• Puerarin administration at middle and high doses significantly upregulated GAP-43 expression in the L4-6 spinal cord segments at 1, 2, and 4 weeks post-injury.
• The treatment reduced triceps surae muscle atrophy on the affected side.
• Nerve fiber regeneration in the damaged spinal cord was promoted by puerarin by 8 weeks after injury.

Conclusions:

• Puerarin activates growth-associated protein 43 in the spinal cord following sciatic nerve injury.
• Puerarin demonstrates a therapeutic role in enhancing neural regeneration and functional recovery after peripheral nerve damage.